Oncology Services For Medical Specialties
-
based in USA
Advancements in cancer treatments are progressing with great speed. Clinical trials offer clinical researchers and care providers more options for their patients, but finding the right trials for their patient population and matching the right patients to trials is complex and time consuming. With AI-enhanced technology and expert support services, Inteliquet offers a comprehensive solution to ...
-
by Sectra ABbased in SWEDEN
Sectra’s enterprise imaging portfolio gives you a unified strategy for all your imaging needs, and lets you improve patient outcome while lowering operational costs. With our solutions, you can reduce the number of systems while providing top-of-the-line diagnostic capabilities spanning both image-intense departments such as radiology, breast imaging, pathology, orthopaedics, and cardiology ...
-
based in USA
Avalia’s patented chemical design lends itself well to the treatment of HPV-associated cancers. Certain strains of HPV are responsible for the onset of cervical cancer, many anogenital cancers and head and neck cancer. Avalia’s preclinical program has shown significantly increased survival rates and cures in models of HPV-associated cancer in combination with approved therapeutic ...
-
based in USA
Champions Oncology’s clinical flow cytometry services are implemented using fully optimized and validated human panels developed to be customizable to meet your clinical trial needs. Champions Oncology leads the industry in clinical flow cytometry expertise and innovative technology that provides you with the highest quality, complex computational results with the ability to interrogate up ...
-
based in USA
Xeno Diagnostics is a provider of in-vitro assays for early-stage drug development. We support biotech companies, pharmaceutical and academic life science organizations to enhance the quality and speed of their research. Our suite of assays and interaction with investigators have been designed to move the process forward. We are truly dedicated to making a difference for our ...
-
based in USA
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
-
Manufactured by Elpisciencebased in CHINA
Elpiscience has assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration ...
-
Manufactured by miraDry, Inc.based in USA
Products and Procedures miraDry, Inc. proprietary miraWave™ technology utilizes microwave energy to precisely deliver energy to target areas. The use of microwave energy has been long established in various fields of medicine from oncology to urology; however, miraDry, Inc. is the first to harness this energy for use in applications in Dermatology and Plastic ...
-
Manufactured by Xenobiotic Detection Systems International, Inc.based in USA
What is LUMI-CELL? Similar to the CALUX bioassay, LUMI-CELL is a screening assay using a recombinant cell line (Human breast Carcinoma cell “VM7Luc4E2”) containing a stably integrated ER-responsive luciferase reporter gene for detection and relative quantitation of estrogenic or antiestrogenic activity of chemicals or extracts. The LUMI-CELL bioassay was endocrine disruptor compounds ...
-
based in USA
Indication: Breast Cancer. Improved detection and differentiation on routine breast ultrasound, enabling faster, more accurate, and cheaper detection and treatment of breast cancer. ISSUED ...
-
based in USA
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
-
Manufactured by Nexelisbased in USA
From Fit-for-Purpose Development to Qualified and Validated Clinical Assays. Nexelis, a Q² Solutions Company, is a leading partner in assay development and technology transfer, with scientific discipline, critical thinking, and agility. Fit-for-purpose assay development on a wide variety of platforms support your small molecule, large molecule, or vaccine program through all phases of ...
-
based in USA
Over 350 Clinical Data Points: Pathology (Dx), oncology (treatment), radiology (imaging), internal medicine (labs), other ...
-
Manufactured by Cloud-Clone Corp.based in USA
These include antisense and antigene drugs, antibody-based drugs, cytokines and protein drugs, mass screening of chemical drugs in vitro and vivo as well. It applies to the study of preclinical validity at home and ...
-
based in USA
Mammograms are x-ray exams of the breast. They are most often used to screen for breast cancer in women who have no symptoms. Mammograms and other breast imaging tests can also be used in women who have breast symptoms, such as a lump or pain, or who have a suspicious change seen on a screening mammogram. Mammography is the only screening tool that has been demonstrated through large randomized ...
-
Manufactured by Exscientiabased in UNITED KINGDOM
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...
-
Manufactured by Grail, Inc.based in USA
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
-
based in GERMANY
The outcome of your research is directly linked to the quality of the used biospecimen. In order to reflect the molecular reality, the biospecimen quality benefits from our standardized sampling by Indivumed study nurses and Indivumed trained personnel. This includes fresh-frozen tissue, FFPE samples, plasma, serum, and urine, as well as prospective collection of fresh tissue. ...
-
Manufactured by Grail, Inc.based in USA
Development of a Blood Test with Prospective Study Cohort of 100,000 Participants. The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants ...
-
Manufactured by Immatics N.V.based in GERMANY
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you